Funds research to develop, validate, and translate digital biomarkers (e.g., wearables, apps, sensors) for Alzheimer's disease detection and monitoring.
Neuroimaging and CSF Biomarkers supports researchers and clinicians developing and validating biomarkers to advance drug development, diagnosis, and monitoring for Alzheimer's disease and related dementias.
Drug Development RFP supports researchers and clinicians developing drugs and devices through IND-enabling studies and early clinical trials to advance treatments for Alzheimer’s disease and related dementias.
Parkinson's Disease Biomarker Innovation and Advancement Program supports teams developing fluid- and imaging-based biomarkers for clinical implementation and broader use in Parkinson's research.
Supports early-career investigators conducting clinical research on Alzheimer’s disease and related dementias to advance understanding and treatment.
The Alzheimer’s Disease Research Grant Program by the IDSA Foundation supports research into infectious and microbial causes of Alzheimer’s, fostering novel scientific approaches and collaboration.